CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen

Blood

Volumn 111, Issue 7, 2008, Pages 3644-3652

  Rodríguez Alba, Juan C ^a,b   Moreno García, Miguel E ^a   Sandoval Montes, Claudia ^a   Rosales Garcia, Víctor H ^a   Santos Argumedo, Leopoldo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b Instituto de Física   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CD23 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE FYN; PROTEIN KINASE LYN; AGAMMAGLOBULINAEMIA TYROSINE KINASE; CD38 PROTEIN, MOUSE; FYN PROTEIN, MOUSE; LYN PROTEIN-TYROSINE KINASE; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CONTROLLED STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MATURE FOLLICULAR B LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; TRANSITIONAL 1 B LYMPHOCYTE; TRANSITIONAL 2 B LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; CAPPING PHENOMENON; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD38; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC CAPPING; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-FYN; SIGNAL TRANSDUCTION; SPLEEN; SRC-FAMILY KINASES;

EID: 43549118443     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-08-107714     Document Type: Article

References (56)

1. Lund FE, Cockayne DA, Randall TD, Solvason N, Schuber F, Howard MC. CD38: a new paradigm in lymphocyte activation and signal transduction. Immunol Rev. 199S;161:79-93.
2. Harada N, Santos-Argumedo L, Chang R, et al. Expression cloning of a cDNA encoding a novel murine B cell activation marker: homology to human CD38. J Immunol. 1993;151:3111-3118.
3. Howard M, Grimaldi JC, Bazan JF, et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science. 1993;262: 1056-1059.
4. Santos-Argumedo L, Teixeira C, Preece G, Kirkham PA, Parkhouse RME. A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels. J Immunol. 1993;151:3119-3130.
5. Kirkham PA, Santos-Argumedo L, Harnett MM, Parkhouse RME. Murine B-cell activation via CD38 and protein tyrosine phosphorylation. Immunology. 1994;83:513-516.
6. Funaro A, Morra M, Calosso L, et al. Role of the human CD38 molecule in B cell activation and proliferation. Tissue Antigens. 1997;49:7-15.
7. Partida-Sanchez S, Goodrich S, Kusser K, Oppenheimer N, Randall TD, Lund FE. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity. 2004;20:279-291.
8. Lund FE, Muller-Steffner H, Romero-Ramirez H, et al. CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase-and NAD glycohydrolase-independent mechanism. Int Immunol. 2008; 18:1029-1042.
9. Kumagai MA, Coustan-Smith E, Murray DJ, et al. Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med. 1995;181:1101-1110.
10. Donis-Hernandez FR, Parkhouse RME, Santos- Argumedo L. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice. Eur J Immunol. 2001;31:1261-1267.
11. Funaro A, Malavasi F. Human CD38, a surface receptor, an enzyme, an adhesion molecule and not a simple marker. J Biol Regul Homeost Agents. 1999;13:54-61.
12. Sandoval-Montes C, Santos-Argumedo L. CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines. J Leukoc Biol. 2005;77:513-521.
13. Jackson DG, Bell Jl. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J Immunol. 1990;144:2811-2815.
14. Malavasi F, Funaro A, Alessio M, et al. CD38: a multi-lineage cell activation molecule with a split personality. Int J Clin Lab Res. 1992:22:73-80.
15. Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J. 1996;10:1408-1417.
16. Deaglio S, Morra M, Mallone R, et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol. 1998;160:395-402.
17. Dianzani U, Funaro A, DiFranco D, et al. Interaction between endothelium and CD4+CD45RA+ lymphocytes: role of the human CD38 molecule. J Immunol. 1994;153:952-959.
18. Wykes MN. Beattie L, Macpherson GG, Hart DN. Dendritic cells and follicular dendritic cells express a novel ligand for CD38 which influences their maturation and antibody responses. Immunology. 2004;113:318-327.
19. Deterre P, Berthelier V, Bauvois B, Dalloul A. Schuber F, Lund F. CD38 in T- and B-cell functions. Chem Immunol. 2000:75:146-168.
20. Lund FE, Yu N, Kim KM, Reth M, Howard MC. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J Immunol. 1996:157:1455- 1467.
21. Funaro A, De Monte LB, Dianzani U, Forni M, Malavasi F. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol. 1993;23: 2407-2411.
22. Deaglio S, Vaisitti T, Billington R, et al. CD38/CD19: a lipid raft-dependent signaling complex in human B cells. Blood. 2007;109:5390-5398.
23. Muñoz P, Navarro MDC, Pavon EJ, et al. CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-ζ subunit of the T cell antigen receptor. J Biol Chem. 2003;278:50791-50802.
24. Kikuchi Y, Yasue T, Miyake K, Kimoto M, Takatsu K. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor α chain: synergistic effects with interleukin 5. Proc Natl Acad Sci USA. 1995;92:11814-11818.
25. Santos-Argumedo L, Lund FE, Heath AW, et al. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int Immunol. 1995:7:163-170.
26. Yasue T, Nishizumi H, Aizawa S, et al. A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc Natl Acad Sci USA. 1997;94:10307-10312.
27. Moreno-Garcia ME, López-Bojo» LN. Zen-tella A, Humphries LA, Rawlings DJ, Santos-Argumedo L. CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)- γ2-independent, protein kinase C,phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade. J Immunol. 2005; 174:2687- 2695.
28. Kaku H, Horikawa K, Obata Y et al. NF-κ;B is required for CD38-mediated induction of Cγ1 germ- line transcripts in murine B lymphocytes. Int Immunol. 2002;14:1055-1064.
29. KitanakaA, Ito C, Coustan-Smith E, Campana D. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD 19 and association of CD 19 with lyn and phosphatidylinositol 3-kinase. J Immunol. 1997;159:184-192.
30. Kitanaka A, Ito G, Nishigaki H, Campana D. CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. Blood. 1996;88:590-598.
31. Cockayne DA, Muchamuel T, Grimaldi JC, et al. Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood. 1998;92:1324-1333.
32. Hardy RR. B-cell commitment: deciding on the players. Curr Opin Immunol. 2003;15:158-165.
33. Fuxa M, Skok JA. Transcriptional regulation in early B-cell development. Curr Opin Immunol. 2007;19:129-136.
34. Ollila J, Vihinen M. B cells. Int J Biochem Cell Biol. 2005;37:518-523.
35. Loder F, Mutschler B, Ray RJ, et al. B-cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med. 1999;190: 75-89.
36. Allman DM, Ferguson SE, Cancro MP. Peripheral B cell maturation: I. Immature peripheral B cells in adults are heat-stable antigen(hi) and exhibit unique signaling characteristics. J Immunol. 1992;149:2533-2540.
37. Allman DM, Ferguson SE, LentzVM, Cancro MP. Peripheral B cell maturation: II. Heat-stable anti- gen(hi) splenic B cells are an immature developmental intermediate in the production of long- lived marrow-derived B cells. J Immunol. 1993; 151:4431-4444.
38. Petro JB, Gerstein RM, Lowe J, Carter RS, Shinners N, Khan WN. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J Biol Chem. 2002; 277:48009-48019.
39. Carsetti R, Köhler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med. 1995:181:2129- 2140.
40. Su TT Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B-cell development. J Immunol. 2002; 168:2101-2110.
41. Su TT, Guo B, Wei B, Braun J, Rawlings DJ. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev. 2004:197:161-178.
42. Batten M, Groom J, Cachero TG, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med. 2000;192:1453-1465.
43. Kövesdi D, Pászty K, Enyedi A, et al. Antigen receptor-mediated signaling pathways in transitional immature B cells. Cell Signal. 2004;16:881-889.
44. Partida-Sanchez S, Gasser A, Fliegert R, et al. Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by ADP-ribose, the major product generated by the CD38 enzyme reaction. J Immunol. 2007;179:7827-7839.
45. Manjarrez-Orduño N, Moreno-García ME, Fink K, Santos-Argumedo L. CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation. Eur J Immunol. 2007;37:358-367.
46. Rolink AG, Schaniel C, Andersson J, Melchers F. Selection events operating at various stages in B-cell development. Curr Opin Immunol. 2001;13: 202-207.
47. Melchers F, Rolink A, Grawunder U, et al. Positive and negative selection events during B lymphopoiesis. CurrOpin Immunol. 1995:7:214-227.
48. Hayakawa K, Asano M, Shinton SA, et al. Positive selection of natural autoreactive B cells. Science. 1999;285:113-116.
49. Martin F, Kearney J F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD 19, and btk. Immunity. 2000;12:39-49.
50. Rawlings DJ, Saffran DC, Tsukada S, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993;261: 358-361.
51. Kurosaki T. Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol. 1999;17: 555-592.
52. Nishizumi H, Taniuchi I, Yamanashi Y, et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 1995;3:549-560.
53. Chan VWF, Meng F, Soriano P, De Franco AL, Lowell CA. Characterization of the B lymphocyte populations in lyn-deficient mice and the role of lyn in signal initiation and down-regulation. Immunity. 1997;7:69-81.
54. Okkenhaug K, Bilancio A, Farjot G, et al. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science. 2002;297: 1031-1034.
55. Clayton E, Bardi G, Bell SE, et al. A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B-cell development and activation. J Exp Med. 2002;196:753-763.
56. Jacob A, Cooney D, Pradhan M, Coggeshall KM. Convergence of signaling pathways on the activation of ERK in B cells. J Biol Chem. 2002;277: 23420-23426.